Dean P Jones Selected Research

Cystine (L-Cystine)

1/2020	Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease.
1/2018	Pilot randomized controlled trial of a Mediterranean diet or diet supplemented with fish oil, walnuts, and grape juice in overweight or obese US adults.
7/2017	Redox theory of aging: implications for health and disease.
1/2016	Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease.
6/2014	Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.
11/2011	The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability.
9/2011	Oxidative stress is associated with impaired arterial elasticity.
2/2011	Cysteine/cystine redox signaling in cardiovascular disease.
1/2010	A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential.
12/2009	Gene and protein responses of human monocytes to extracellular cysteine redox potential.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dean P Jones Research Topics

Disease

40	Inflammation (Inflammations) 04/2022 - 09/2007
15	Infections 01/2022 - 04/2003
14	Neoplasms (Cancer) 01/2022 - 11/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2006
7	Parkinson Disease (Parkinson's Disease) 05/2015 - 01/2007
7	Carcinoma (Carcinomatosis) 01/2006 - 08/2002
6	Lung Diseases (Lung Disease) 01/2021 - 10/2007
6	Obesity 12/2020 - 10/2009
6	Atherosclerosis 04/2016 - 06/2005
5	Insulin Resistance 05/2022 - 01/2017
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 09/2004
5	Asthma (Bronchial Asthma) 01/2021 - 06/2011
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2006
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2016
5	Non-alcoholic Fatty Liver Disease 10/2019 - 07/2009
5	Lung Injury 01/2019 - 10/2007
5	Neuroblastoma 01/2019 - 10/2006
5	Macular Degeneration (Age-Related Maculopathy) 10/2018 - 03/2005
5	Short Bowel Syndrome 12/2009 - 11/2004
4	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2004
4	Pneumonia (Pneumonitis) 01/2022 - 06/2014
4	Adenoma (Adenomas) 01/2022 - 03/2010
4	Overweight 12/2020 - 01/2018
4	Critical Illness (Critically Ill) 01/2020 - 01/2008
4	Malaria 07/2019 - 08/2014
4	Cystic Fibrosis (Mucoviscidosis) 10/2018 - 01/2017
4	Fibrosis (Cirrhosis) 01/2017 - 08/2005
4	Hypertension (High Blood Pressure) 11/2011 - 09/2005
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2020
3	Idiopathic Pulmonary Fibrosis 01/2021 - 10/2007
3	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2005
3	Tuberculosis (Tuberculoses) 01/2020 - 01/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019 - 08/2012
3	Weight Loss (Weight Reduction) 01/2018 - 04/2011
3	Alcoholism (Alcohol Abuse) 01/2016 - 01/2010
3	Acute Lung Injury 01/2016 - 01/2009
3	Fatty Liver 01/2016 - 11/2011
3	Necrosis 09/2014 - 11/2004
3	Chronic Disease (Chronic Diseases) 09/2014 - 12/2003
3	Colonic Neoplasms (Colon Cancer) 01/2006 - 04/2004

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2006
22	AntioxidantsIBA 01/2020 - 04/2003
21	Glutathione (Reduced Glutathione)IBA 01/2020 - 08/2002
17	Sulfhydryl Compounds (Thiols)IBA 09/2014 - 12/2002
16	Cysteine (L-Cysteine)FDA Link 01/2018 - 08/2002
15	Cystine (L-Cystine)IBA 01/2020 - 07/2005
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
12	Glutathione Disulfide (GSSG)FDA LinkGeneric 10/2012 - 08/2002
11	Oxidants (Oxidizing Agents)IBA 01/2020 - 09/2002
10	Amino Acids FDA Link 10/2021 - 01/2009
9	C-Reactive ProteinIBA 01/2021 - 01/2005
9	ThioredoxinsIBA 01/2016 - 09/2002
8	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
7	Biological ProductsIBA 04/2022 - 06/2005
7	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2010
6	CadmiumIBA 01/2022 - 12/2013
6	CytokinesIBA 01/2022 - 10/2003
6	LipidsIBA 01/2020 - 07/2012
6	ManganeseIBA 01/2019 - 03/2010
6	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014 - 11/2004
6	DisulfidesIBA 10/2012 - 12/2002
5	Insulin (Novolin)FDA Link 05/2022 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 11/2011
5	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 11/2016
5	Glutamine (L-Glutamine)FDA Link 01/2020 - 01/2007
4	Glycerophospholipids (Phosphoglycerides)IBA 04/2022 - 11/2016
4	Tyrosine (L-Tyrosine)FDA Link 04/2022 - 01/2016
4	Arginine (L-Arginine)FDA Link 04/2022 - 01/2019
4	Linoleic Acid (Linoleate)IBA 01/2022 - 01/2019
4	EnzymesIBA 01/2022 - 08/2009
4	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 11/2016
4	Histidine (L-Histidine)FDA Link 01/2022 - 11/2019
4	Triglycerides (Triacylglycerol)IBA 12/2020 - 07/2012
4	Carnitine (L-Carnitine)FDA LinkGeneric 10/2020 - 10/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 10/2003
4	FructoseIBA 01/2017 - 07/2009
4	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2006
4	ParaquatIBA 01/2014 - 01/2007
3	PesticidesIBA 05/2022 - 04/2007
3	Urea (Carbamide)FDA LinkGeneric 04/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
3	Nucleic AcidsIBA 01/2022 - 11/2018
3	Drinking WaterIBA 01/2022 - 04/2003
3	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2016
3	Galactose (Galactopyranose)FDA LinkGeneric 10/2021 - 01/2013
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 01/2019
3	CalciumIBA 01/2021 - 09/2004
3	Methionine (L-Methionine)FDA Link 01/2020 - 01/2018
3	Branched-Chain Amino AcidsIBA 12/2019 - 01/2019
3	InterferonsIBA 01/2019 - 11/2016
3	CholesterolIBA 07/2017 - 01/2016
3	Cholecalciferol (Vitamin D3)FDA Link 05/2017 - 10/2011
3	Messenger RNA (mRNA)IBA 07/2016 - 07/2009
3	Angiotensin IIIBA 04/2016 - 04/2007
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2014 - 04/2011
3	ManebIBA 01/2014 - 06/2011
3	Free RadicalsIBA 01/2014 - 07/2009
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2013 - 01/2010

Therapy/Procedure

10	Therapeutics 01/2020 - 11/2004